Predicting early allograft failure and mortality after liver transplantation: The role of the postoperative model for end-stage liver disease score

Liver Transplantation

Volumn 19, Issue 5, 2013, Pages 534-542

  Wagener, Gebhard ^a   Raffel, Brian ^a   Young, Andrew T ^a   Minhaz, Moury ^a   Emond, Jean ^b  

^a Columbia University ^*  (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ACUTE LIVER FAILURE; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; ALLOGRAFT FAILURE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE LIVER DISEASE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CRYPTOGENIC CIRRHOSIS; FEMALE; GRAFT FAILURE; HEPATITIS B; HEPATITIS C; HUMAN; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; NONALCOHOLIC FATTY LIVER; POSTOPERATIVE PERIOD; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETRANSPLANTATION; RISK ASSESSMENT; SURGICAL RISK;

ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; END STAGE LIVER DISEASE; FEMALE; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION, HOMOLOGOUS;

EID: 84876944041     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23634     Document Type: Article

References (24)

1. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 1993; 55: 807-813.
2. Brokelman W, Stel AL, Ploeg RJ,. Risk factors for primary dysfunction after liver transplantation in the University of Wisconsin solution era. Transplant Proc 1999; 31: 2087-2090.
3. Jung B, Cisse M, Chanques G, Arsac E, Bismuth M, Panaro F, et al. Causes of early mortality after liver transplantation: a twenty-years single centre experience [in French]. Ann Fr Anesth Reanim 2011; 30: 899-904.
4. Chen GH, Fu BS, Cai CJ, Lu MQ, Yang Y, Yi SH, et al. A single-center experience of retransplantation for liver transplant recipients with a failing graft. Transplant Proc 2008; 40: 1485-1487.
5. Crivellin C, De Martin E, Germani G, Gambato M, Senzolo M, Russo FP, et al. Risk factors in liver retransplantation: a single-center experience. Transplant Proc 2011; 43: 1110-1113.
6. Shen ZY, Zhu ZJ, Deng YL, Zheng H, Pan C, Zhang YM, et al. Liver retransplantation: report of 80 cases and review of literature. Hepatobiliary Pancreat Dis Int 2006; 5: 180-184.
7. Deschênes M, Belle SH, Krom RA, Zetterman RK, Lake JR,. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation 1998; 66: 302-310.
8. Olthoff KM, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl 2010; 16: 943-949.
9. Stockmann M, Lock JF, Malinowski M, Seehofer D, Puhl G, Pratschke J, Neuhaus P,. How to define initial poor graft function after liver transplantation?-a new functional definition by the LiMAx test. Transpl Int 2010; 23: 1023-1032.
10. Xu X, Ling Q, Wu J, Chen J, Gao F, Feng XN, Zheng SS,. A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation. Liver Int 2007; 27: 816-824.
11. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
12. Becker DM, Humphries JE, Walker FB IV, DeMong LK, Bopp JS, Acker MN,. Standardizing the prothrombin time. Calibrating coagulation instruments as well as thromboplastin. Arch Pathol Lab Med 1993; 117: 602-605.
13. Hanley JA, McNeil BJ,. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
14. Hanley JA, McNeil BJ,. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-843.
15. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
16. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC,. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871.
17. Asrani SK, Kim WR,. Model for End-Stage Liver Disease: end of the first decade. Clin Liver Dis 2011; 15: 685-698.
18. Bernardi M, Gitto S, Biselli M,. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol 2011; 54: 1297-1306.
19. Trotter JF, Osgood MJ,. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes. JAMA 2004; 291: 1871-1874.
20. Varotti G, Grazi GL, Vetrone G, Ercolani G, Cescon M, Del Gaudio M, et al. Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. Clin Transplant 2005; 19: 492-500.
21. Nanashima A, Pillay P, Verran DJ, Painter D, Nakasuji M, Crawford M, et al. Analysis of initial poor graft function after orthotopic liver transplantation: experience of an Australian single liver transplantation center. Transplant Proc 2002; 34: 1231-1235.
22. Rosen HR, Martin P, Goss J, Donovan J, Melinek J, Rudich S, et al. Significance of early aminotransferase elevation after liver transplantation. Transplantation 1998; 65: 68-72.
23. Demler OV, Pencina MJ, D'Agostino RB Sr,. Misuse of DeLong test to compare AUCs for nested models. Stat Med 2012; 31: 2577-2587.
24. Wolfe R, Hanley J,. If we're so different, why do we keep overlapping? When 1 plus 1 doesn't make 2. CMAJ 2002; 166: 65-66.